Clonidine reduces dopamine and increases GABA in the nucleus accumbens: An in vivo microdialysis study

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 3, 1998, Pages 695-701

  Murai, Tameatsu ^a   Yoshida, Yukihiro ^a   Koide, Shigeyo ^a   Takada, Koji ^a   Misaki, Toru ^a   Koshikawa, Noriaki ^a   Cools, Alexander R ^b  

^a NIHON UNIVERSITY   (Japan)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Clonidine; Dopamine release; GABA release; Midazolam; Nucleus accumbens

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; BETA CARBOLINE 3 CARBOXYLIC ACID; BICUCULLINE; CLONIDINE; DOPAMINE; FLUMAZENIL; GABAERGIC RECEPTOR AFFECTING AGENT; IDAZOXAN; MIDAZOLAM; MIDAZOLAM MALEATE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DOPAMINE RELEASE; DRUG BINDING SITE; DRUG EFFECT; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIMBIC CORTEX; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; VENTRAL TEGMENTUM;

EID: 0031853338     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00050-1     Document Type: Article

References (33)

1. Benveniste, H.; Hansen, A. J.; Ottosen, N. S.: Determination of brain interstitial concentration by microdialysis. J. Neurochem. 52:1741-1750; 1989.
2. 3H]-clonidine to identify imidazoline receptors in the rabbit brainstem. Br. J. Pharmacol. 110:1537-1543; 1993.
3. Churchill, L.; Kalivas, P. W.: A topographically organized gamma-aminobutyric acid projection from the ventral pallidum to the nucleus accumbens in the rat. J. Comp. Neurol. 345:579-595; 1994.
4. 2-mediated analgesia and other non-cardiovascular therapeutic uses. Life Sci. 56:63-74; 1994.
5. 9 circuitries. In: Wolters, E. L.; Scheltens, P., eds. Mental disfunction in Parkinson's disease. Amsterdam: Vrije Universiteit; 1993:49-67.
6. Cools, A. R.; van den Bos, R.; Ploeger, G.; Ellenbroek, B. A.: Gating function of noradrenaline in the ventral striatum: Its role in behavioural responses to environmental and pharmacological challenges. In: Willner, P.; Scheel-Krüger, J., eds. The mesolimbic dopamine system: From motivation to action. Chichester: John Wiley & Sons; 1991:141-173.
7. Di Chiara, G.; Imperato, A.: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:5274-5278; 1988.
8. Finlay, J. M.; Damsma, G.; Fibger, H. C.: Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration. Psychopharmacology (Berlin) 106:202-208; 1992.
9. Horváth, G.; Szikszay, M.; Rubicsek, G.; Benedek, G.: An isobolographic analysis of the hypnotic effects of combinations of dexmedetomidine with fentanyl or diazepam in rats. Life Sci. 50:215-220; 1992.
10. Invernizzi, R.; Pozzi, L.; Samanin, R.: Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats. Neuropharmacology 30:575-578; 1991.
11. Johnston, R. R.; Way, W. L.; Miller, R. D.: Alteration of anesthetic requirement by amphetamine. Anesthesiology 36:357-363; 1972.
12. Johnston, R. R.; White, P. F.; Way, W. L.; Miller, R. D.: The effect of levodopa on halothane anesthetic requirements. Anesth. Analg. 54:178-181; 1975.
13. Kanto, J.: Benzodiazepines as oral premedicants. Br. J. Anaesth. 53:1179-1188; 1981.
14. Koshikawa, N.: Role of the nucleus accumbens and the striatum in the production of turning behaviour in intact rats. Rev. Neurosci. 5:331-346; 1994.
15. Lindefors, N.; Amberg, G.; Ungerstedt, U.: Intracerebral microdialysis, I. Experimental studies of diffusion kinetics. J. Pharmacol. Methods. 22:141-156; 1989.
16. Matthews, J. N. S.; Altman, D. G.; Campbell, M. J.; Royston, P.: Analysis of serial measurements in medical research. Br. Med. J. 300:230-235; 1990.
17. 2-autoreceptors. Eur. J. Pharmacol. 157:23-29; 1988.
18. Murai, T.; Koshikawa, N.; Kanayama, T.; Takada, K.; Tomiyama, K.; Kobayashi, M.: Opposite effects of midazolam and β-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis. Eur. J. Pharmacol. 261:65-71; 1994.
19. Murai, T.; Kyoda, N.; Misaki, T.; Takada, K.; Sawada, S.; Machida T.: Effects of clonidine on intravenous sedation with midazolam. Anesth. Prog. 42:135-138; 1995.
20. 3H]dopamine release from rat nucleus accumbens slices. Brain Res. 334: 235-242; 1985.
21. Paxinos, G.; Watson, C.: The rat brain in stereotaxic coordinates. New York: Academic Press; 1986.
22. Pijnenburg, A. J. J.; Honig, W. M. M.; van der Heyden, J. A. M.; van Rossum, J. M.: Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur. J. Pharmacol. 35:45-58; 1976.
23. 2-adrenoceptors regulating GABA release. Neurosci. Lett. 76:363-367; 1987.
24. Pittaluga, A.; Raiteri, M.: Clonidine enhances the release of endogenous γ-aminobutyric acid through alpha-2 and alpha-1 presynaptic adrenoceptors differentially located in rat cerebral cortex subregions. J. Pharmacol. Exp. Ther. 245:682-686; 1988.
25. 2-adrenergic agonists and benzodiazepines in rats. Anesthesiology 76:1004-1011; 1992.
26. Segal, I. S.; Jarvis, D. J.; Duncan, S. R.; White, P. F.; Maze, M.: Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period. Anesthesiology 74:220-225; 1991.
27. Segal, I. S.; Walton, J. K.; Irwin, I.; Delanney, L. E.; Ricaurte, G. A.; Langston, J. W.; Maze, M.: Modulating role of dopamine on anesthetic requirements. Eur. J. Pharmacol. 186:9-15; 1990.
28. - ion channel modulated by multiple drug-binding sites. Trends Pharmacol. Sci. 13:446-450; 1992.
29. Stoelting, R. K.; Celasser, C. W.; Marty, R. C.: Effect of cocaine administration on halothane MAC in dogs. Anesth. Analg. 54:422-424; 1975.
30. Takada, K.; Murai, T.; Kanayama, T.; Koshikawa, N.: Effects of midazolam and flunitrazepam on the release of dopamine from rat striatum measured by in vivo microdialysis. Br. J. Anaesth. 70:181-185; 1993.
31. 2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices. Naunyn Schmiedebergs Arch. Pharmacol. 350:473-481; 1994.
32. 2-agonist binding sites in the rat and human central nervous system; Analysis of some functional correlates of the pharmacological effects of clonidine and related adrenergic agents. Brain Res. Rev. 319:69-101; 1984.
33. Zetterström, T.; Fillenz, M.: Local administration of flurazepam has different effects on dopamine release in striatum and nucleus accumbens: A microdialysis study. Neuropharmacology 29:129-134; 1990.